Drug effects in melanoma: tumor-specific interactions of proflavine and ethidiumbromide.
D000166:Acridines / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002471:Cell Transformation, Neoplastic; D002499:Centrifugation, Density Gradient; D004396:Coloring Agents / Q000494:pharmacology / Q000627:therapeutic use; D006224:Cricetinae; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003864:Depression, Chemical; D003959:Diamines / Q000494:pharmacology / Q000627:therapeutic use; D004996:Ethidium / Q000494:pharmacology / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000382:microbiology; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009858:Oncogenic Viruses / Q000201:enzymology; D012313:RNA; D012328:RNA Viruses / Q000201:enzymology; D012334:RNA, Neoplasm / Q000032:analysis / Q000096:biosynthesis; D018894:Reverse Transcriptase Inhibitors; D013698:Templates, Genetic; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D000166:Acridines; D000970:Antineoplastic Agents; D004396:Coloring Agents; D004273:DNA, Neoplasm; D003959:Diamines; D012334:RNA, Neoplasm; D018894:Reverse Transcriptase Inhibitors; D014316:Tritium; D012313:RNA; D004996:Ethidium; D014529:Uridine